Neurocrine Biosciences, Inc <NBIX.O>: Truist Securities raises target price to $213 from $200
NBIX•Related News
Clearmind signs LOI to buy 51% stake in EV wireless charging firm for $2.5 million
CMND•
AGCO names Indira Agarwal CFO in leadership reshuffle
AGCO•
Venu Holding closes $25 million secured convertible debenture financing for Regent Bank Amphitheater project
VENU•
Oncology Institute to trade on Nasdaq as STLN from Aug. 4, replacing TOI
TOI•
FDA Provides Further Regulatory Guidance To Acurx Pharmaceuticals For The Ibezapolstat Clinical Development Program
ACXP•